Xihao Hu,Jian Zhang,Jin Wang,Jingxin Fu,Taiwen Li,Xiaoqi Zheng,Binbin Wang,Shengqing Gu,Peng Jiang,Jingyu Fan,Xiaomin Ying,Jing Zhang,Michael C. Carroll,Kai W. Wucherpfennig,Nir Hacohen,Fan Zhang,Peng Zhang,Jun S. Liu,Bo Li,X. Shirley Liu

Abstract:Tumor-infiltrating B cells are an important component in the microenvironment but have unclear anti-tumor effects. We enhanced our previous computational algorithm TRUST to extract the B cell immunoglobulin hypervariable regions from bulk tumor RNA-sequencing data. TRUST assembled more than 30 million complementarity-determining region 3 sequences of the B cell heavy chain (IgH) from The Cancer Genome Atlas. Widespread B cell clonal expansions and immunoglobulin subclass switch events were observed in diverse human cancers. Prevalent somatic copy number alterations in the MICA and MICB genes related to antibody-dependent cell-mediated cytotoxicity were identified in tumors with elevated B cell activity. The IgG3–1 subclass switch interacts with B cell–receptor affinity maturation and defects in the antibody-dependent cell-mediated cytotoxicity pathway. Comprehensive pancancer analyses of tumor-infiltrating B cell–receptor repertoires identified novel tumor immune evasion mechanisms through genetic alterations. The IgH sequences identified here are potentially useful resources for future development of immunotherapies.

Publisher Correction: Landscape of B cell immunity and related immune evasion in human cancers

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures

Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Publisher Correction: Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Landscape of B cell immunity and related immune evasion in human cancers

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Author Correction: A Next-Generation Tumor-Targeting IL-2 Preferentially Promotes Tumor-Infiltrating CD8+ T-cell Response and Effective Tumor Control

Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling

Author Correction: A Novel Cancer Vaccine with the Ability to Simultaneously Produce Anti-Pd-1 Antibody and GM-CSF in Cancer Cells and Enhance Th1-biased Antitumor Immunity

Publisher Correction: A DNA nanodevice-based vaccine for cancer immunotherapy

Corrigendum: Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients

Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment

Author Correction: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Publisher Correction: Intercellular Interaction Dictates Cancer Cell Ferroptosis Via NF2–YAP Signalling

Corrigendum: A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines

Author Correction: Cyclin D–CDK4 Kinase Destabilizes PD-L1 Via Cullin 3–SPOP to Control Cancer Immune Surveillance

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis